Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
BMC Clinical Pharmacology|May 10, 2007
Does atenolol differ from other beta-adrenergic blockers?Ivar Aursnes, Jan-Bjørn Osnes, Ingunn Fride Tvete, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|August 29, 2023
Can acetate via FFA receptors contribute to the diabetogenic effect of statins?Finn Olav Levy, Jan-Bjørn OsnesTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 27, 2004
[Mercury, fish, fish oil and the risk of cardiovascular disease]Knud Landmark, Ivar AursnesPharmacoepidemiology and Drug Safety|April 3, 2008
Common adverse events associated with an SSRI: meta-analysis of early paroxetine dataIvar Aursnes, Marianne Klemp GjertsenCardiovascular Drugs and Therapy|March 26, 2003
Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapyAsmund Reikvam, Elena Kvan, Ivar AursnesAnalytical Biochemistry|October 4, 2008
Calculating reaction rate constants and estimating the efficacy of selective enzyme inhibitorsHilde Eikemo, Tor Skomedal, Finn Olav Levy, et al.BMC Health Services Research|June 19, 2007
Deficient supplies of drugs for life threatening diseases in an African communityNorman N Lufesi, Marit Andrew, Ivar AursnesTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 9, 2002
[Bayesian thinking on its way into medical statistics?]Ivar Aursnes, Bent Natvig, Ingunn Fride TveteScandinavian Cardiovascular Journal : SCJ|July 26, 2003
Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular functionAasmund Reikvam, Elena Kvan, Knud Landmark, et al.Blood Pressure|April 18, 2003
Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortalityKnud Landmark, Ivar Aursnes, Elena Kvan, et al.Pageof 6